FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
GlobalData on MSN1d
Roche reports positive data from Phase III influenza treatment trialAccording to the findings, the antiviral treatment demonstrated to significantly reduce the transmission of influenza viruses ...
From July 24 to 26, 2024, Porter Novelli Public Services fielded a nine-question online survey developed with the CDC to ...
Baloxavir marboxil significantly reduced the likelihood of influenza transmission from the infected patient to the household contacts. Treatment with baloxavir marboxil significantly reduced the risk ...
Chronic health conditions can be made worse by the flu, particularly those that tax your immune system and its ability to ...
Health officials on Thursday said they don’t know how a Missouri person caught bird flu but believe it may be a rare instance ...
In preparation for the chilly months ahead, maintaining optimal wellness is on everyone’s mind. The shift in seasons often ...
October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.
The Centers for Disease Control is warning that a drop in vaccinations in the U.S. may have increased flu deaths among ...
9h
Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...
Raipur: The Rajnandgaon district is witnessing an outbreak of swine flu cases, with 15 patients identified so far this month.
Zacks.com on MSN7h
Roche Antiviral Drug Reduces Transmission in Late-stage StudyRoche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback